STOCK TITAN

Kewaunee Scientific (KEQU) awards 2,635 restricted stock units to SVP

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Ranade Mandar reported acquisition or exercise transactions in this Form 4 filing.

Kewaunee Scientific senior vice president of IT & Engineering Mandar Ranade received a grant of 2,635 restricted stock units tied to the company’s common stock. Each unit represents a right to one share. The award will vest in three equal annual installments beginning on June 30, 2027, contingent on continued employment.

Positive

  • None.

Negative

  • None.
Insider Ranade Mandar
Role SVP, IT & Engineering
Type Security Shares Price Value
Grant/Award Restricted Stock Units FY27 2,635 $0.00 --
Holdings After Transaction: Restricted Stock Units FY27 — 2,635 shares (Direct, null)
Footnotes (1)
  1. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. The restricted stock units shall vest in three equal annual installments beginning June 30, 2027, subject to the reporting person's continued employment with the Company.
RSU grant size 2,635 units Restricted Stock Units FY27 granted to SVP Mandar Ranade
Exercise/conversion price $0.00 per unit Restricted stock units granted at no cash exercise price
Underlying shares 2,635 shares Each RSU represents one share of common stock
Post-transaction RSUs 2,635 units Total restricted stock units held after the grant
Vesting start date June 30, 2027 First of three equal annual vesting installments
Restricted Stock Units financial
"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
contingent right financial
"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."
vest financial
"The restricted stock units shall vest in three equal annual installments beginning June 30, 2027, subject to the reporting person's continued employment with the Company."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
grant/award acquisition financial
"transaction_action": "grant/award acquisition""
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Ranade Mandar

(Last)(First)(Middle)
2700 WEST FRONT STREET

(Street)
STATESVILLE NORTH CAROLINA 28677

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
KEWAUNEE SCIENTIFIC CORP /DE/ [ KEQU ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
SVP, IT & Engineering
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/24/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units FY27(1)06/24/2026A2,635 (2) (2)Common Stock2,635$02,635D
Explanation of Responses:
1. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
2. The restricted stock units shall vest in three equal annual installments beginning June 30, 2027, subject to the reporting person's continued employment with the Company.
Remarks:
/s/ Donald T. Gardner III, Attorney-in-fact06/25/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Kewaunee Scientific (KEQU) report for Mandar Ranade?

Kewaunee Scientific reported that SVP Mandar Ranade received 2,635 restricted stock units. These units are a form of equity compensation that may convert into common shares if vesting conditions, primarily continued employment, are satisfied over time.

How many restricted stock units did KEQU grant to Mandar Ranade?

Mandar Ranade received a grant of 2,635 restricted stock units. Each unit represents a contingent right to receive one share of Kewaunee Scientific’s common stock if the vesting schedule and employment conditions are met in future years.

What does each restricted stock unit represent for KEQU insiders?

Each restricted stock unit granted to the KEQU executive represents a contingent right to receive one share of common stock. The units do not become actual shares until they vest, aligning executive compensation with the company’s long-term performance and retention goals.

When will Mandar Ranade’s KEQU restricted stock units vest?

The 2,635 restricted stock units granted to Mandar Ranade will vest in three equal annual installments starting on June 30, 2027. Vesting is conditioned on his continued employment with Kewaunee Scientific through each vesting date under the award’s terms.

Did Mandar Ranade buy or sell KEQU shares in this Form 4 filing?

The Form 4 shows an acquisition through a grant of restricted stock units, not an open-market buy or sale. The transaction is coded as an award (code A), reflecting equity-based compensation rather than a discretionary stock trade in the public market.